CARA: Cara Therapeutics, Inc. Quarterly Revenue Growth

CARA (Cara Therapeutics, Inc.) - company brandmark

Following the closure of key trial phases and the departure of partners, ecosystem development has stalled. Cara Therapeutics, Inc. (CARA) is currently focusing on pruritus therapy for patients with renal failure within a segment of stable demand. This niche monopoly allows the company to independently determine its pricing power. This quarterly sales growth chart illustrates the current trend, where the 0.00 mark reflects the latest data.

CARA Cara Therapeutics Inc. Revenue Dynamics QoQ (07/04/2022 - 11/21/2026)

Summary analytical data breakdowns for Cara Therapeutics, Inc (CARA)

- current quotes and average value forecast:
Summary company analytics:caratherapeutics.com (CARA)
Flagship merchandise of Cara Therapeutics Inc.

Against the backdrop of the R&D pipeline freeze at Cara Therapeutics, Inc. (CARA), this indicator assesses the effectiveness of current license monetization by measuring cash flow growth rates. By analyzing the relative quarterly revenue change, an investor can see the percentage difference between current and past sales, enabling the timely identification of business stagnation and an assessment of the company's resilience during a period of cost reduction.

Competitors of Cara Therapeutics, Inc.

BIIB - Revenue Growth QoQ|NBIX (Neurocrine Biosciences) - Sales Growth QoQ|RGC: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Axsome (AXSM)|Revenue Growth QoQ ACADIA Pharmaceuticals Inc|Quarterly Sales Growth Xenon Pharmaceuticals Inc (XENE)|Quarterly Revenue Growth VKTX|Quarterly Revenue Growth supernus.com (SUPN)|Revenue Growth QoQ Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Revenue Dynamics QoQ|Harmony Corp - Quarterly Revenue Growth|BHVN: Revenue Growth QoQ|AMLX: Quarterly Revenue Growth|TRVI: Sales Change QoQ|Revenue Growth QoQ Praxis Medicines|Quarterly Revenue Growth Rate Anavex AVXL|Revenue Growth QoQ CeriBell Corp (CBLL)|Sales Change QoQ PRTA|Quarterly Revenue Growth ALEC (Alector)|Annexon (ANNX) - Quarterly Revenue Growth Rate|OMER - Revenue Growth QoQ|NGNE (Neurogene) - Sales Growth QoQ|ACIU: Quarterly Revenue Growth|VYGR - Quarterly Sales Growth Rate|Revenue Growth QoQ Neumora Therapeutics, Inc.|Sales Growth QoQ SCLX (Scilex)|Quarterly Sales Growth TVGN (Tevogen Bio)|Quarterly Revenue Growth Alpha Cognition Inc (ACOG)|Quarterly Revenue Growth CGTX (cogrx.com)|Quarterly Sales Growth Rate Inhibikase Pharma (IKT)|SAVA: Quarterly Sales Growth|Quarterly Sales Growth Rate Assertio ASRT|COYA (coyatherapeutics.com) - Quarterly Sales Growth|Sales Growth QoQ VTGN|OVID (Ovid Therapeutics) - Quarterly Revenue Growth|Acumen Pharmaceuticals, Inc (ABOS) - Quarterly Sales Growth Rate|Revenue Growth QoQ CervoMed, Inc. (CRVO)|ATHE - Quarterly Revenue Growth Rate|Quarterly Revenue Growth CLNN (Clene Inc.)|Quarterly Sales Growth Rate PepGen Inc. (PEPG)|JUNS - Revenue Growth QoQ|Quarterly Revenue Growth Rate Relmada Corp|ANVS (Annovis Bio, Inc.) - Quarterly Sales Growth|Grace Tx (GRCE) - Quarterly Revenue Growth|Quarterly Sales Growth AIFF|Quarterly Revenue Growth anewmeds.com|Revenue Growth QoQ NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals Holdings) - Quarterly Revenue Increase|MetaVia - Quarterly Sales Growth|NRXS: Sales Growth QoQ|Helius Medical Technologies, Inc. - Quarterly Revenue Growth|PASG: Revenue Growth QoQ|Neuphoria (NEUP) - Revenue Growth QoQ|Minerva Neurosciences - Quarterly Revenue Increase|ATHA (Athira Pharma, Inc.) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate addextherapeutics.com ADXN|Quarterly Sales Growth ALZN (Alzamend Neuro Inc.)|CYCN (Cyclerion Therapeutics, Inc.) - Quarterly Revenue Increase|Quarterly Revenue Growth PTIX (Protagenic)|Quarterly Revenue Growth pasitheaclinics.com KTTA|CRGT - Revenue Growth QoQ|Quarterly Revenue Increase ATXI (Avenue Therapeutics)|BCLI: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Chromocell Therapeutics Corp (CHRO)|Quarterly Sales Growth ELYM|Quarterly Revenue Growth Rate intracellulartherapies.com ITCI|Revenue Growth QoQ Longboard Pharmaceuticals (LBPH)|MRNS (Marinus Pharmaceuticals) - Quarterly Revenue Increase|Revenue Growth QoQ NKGen NKGN|Quarterly Revenue Growth NeuroBo Pharmaceuticals Inc NRBO|SAGE: Quarterly Sales Growth|Quarterly Sales Growth Rate Synaptogenix, Inc SNPX|TRVN: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Vigil Neuroscience (VIGL)|Revenue Growth QoQ Anew Medical, Inc.|CERE (Cerevel Therapeutics, Inc.) - Sales Change QoQ